Pembrolizumab Injection: Best Price & Exclusive Info | Tiruvallur| Tamil Nadu| India
Drug Category
Immunotherapy
Drug name
Pembrolizumab
Complete Drug Name
Pembrolizumab Injection
Mode of Delivery
Injection
Brand
Brand name: Keytruda Manufacturer: Merck & Co., Inc.
Dosage/Dose
Pembrolizumab Dose: 200mg intravenous infusion every 21 days
Types of Cancer & Indication
Pembrolizumab is approved for treating a variety of cancers, such as melanoma, non-small cell lung cancer, head and neck squamous cell carcinoma, classical Hodgkin's lymphoma, urothelial carcinoma, and gastric and esophageal malignancies. Additionally, it is effective against tumors with microsatellite instability or impaired mismatch repair. This medication strengthens the immune system's ability to combat and eliminate tumor progression effectively.
Mechanism of Action
Pembrolizumab is a revolutionary immunotherapy agent that empowers patients' immune defenses to identify and eradicate malignant cells. By cunningly disrupting the PD-1 protein's function – which allows cancer to evade immunity – it bolsters the immune response. With exceptional adaptability, pembrolizumab proficiently combats diverse cancer types, heralding a cutting-edge epoch in individualized cancer treatment alternatives.
Mechanism of Resistance
Resistance to Pembrolizumab injection emerges due to alterations in cancer cell structures, impeding immune checkpoint suppression and limiting T-cell engagement. Consequently, displaying cancer antigens dwindles, and suppressive components escalate, thereby diminishing pembrolizumab's potency and weakening its combative abilities in restraining cancer proliferation.
Side Effects
Pembrolizumab injection usage might lead to a range of unwelcome effects, including persistent tiredness, nonstop cough, feelings of nausea, and worsened skin issues. In particular cases, this medicinal solution can trigger critical outcomes such as auto-destructive organ attacks, pneumonic inflammations, liver-related problems or significant infusion-related complications. Continuous observation is crucial to promptly identify and tackle these potential hazards.
Combination Therapy
Efficient cancer treatment with Pembrolizumab can be achieved by partnering it with suitable drugs contingent on the cancer type. In cases of non-squamous non-small cell lung cancer (NSCLC), blending pembrolizumab with pemetrexed and platinum-sourced chemotherapeutics like cisplatin or carboplatin is a prevalent strategy. Moreover, the FDA permits the simultaneous application of pembrolizumab and axitinib for tackling advanced renal cell carcinoma (RCC). Engaging a healthcare professional is crucial for tailoring ideal therapeutic approaches.
Final Cost
Typical Pembrolizumab Injection price: ₹65,000 in India. The above price is specific for Tiruvallur, Tamil Nadu, India